Kathleen Kennedy Townsend Sells Cape Cod Home for 16 Million Quick Offer Highlights Luxury Demand Quantum Computing Stocks Surge as US Unveils 2 Billion Funding Plan for Nine Firms Microsoft in Talks to Supply Custom AI Chips to Anthropic Following 5 Billion Investment US Seeks to Expand American AI Integration Across Asia After TrumpXi Engagement Tech Media Telecom Roundup Market Talks Highlight DeepSeek and SoFi Wall Street Climbs Dow Sets New Record as Improving Middle East Outlook Boosts Investor Sentiment Warrior Met Coal HCC Q1 2026 Earnings EPS Misses Estimates Amid Margin Headwinds CVLG Q1 2026 Earnings EPS Misses Estimates as Profitability Pressures Persist Unisys Q1 2026 Earnings EPS Surges Past Expectations Despite Net Loss OPRT Q1 2026 Earnings EPS Surpasses Estimates by 243 Despite Stock Decline DCTH Q1 2026 Earnings Narrowed Loss Beats Estimates Amid Continued Commercial Progress WLTH Q1 2026 Earnings EPS Miss Widens as Costs Outpace Estimates nCino Inc NCNO Rises 141 as Stock Approaches Key Resistance Level Harvard Ave Acquisition Corporation HAVA Holds Steady at 1008 Amid Minimal Volatility Ross Stores ROST Slips 072 as Retail Sector Faces Mixed Signals Palatin Technologies PTN Slides 3 Breaking Key Support Levels Under Review Ryman Hospitality Properties RHP Hovers Near Support as Hospitality Sector Faces Headwinds Rubio Assures NATO Allies as Trump Reverses Course on Poland Troop Deployment SRRK Q1 2026 Earnings WiderthanExpected Loss Amid Clinical Progress Minerva Neurosciences NERV Edges Lower Near Support Level Amid Quiet Trading ACRV Q1 2026 Earnings Narrowerthanexpected loss underscores disciplined cash management FWDI Q1 2026 Earnings A Sharp Earnings Surprise in a Quiet Quarter HLT Q1 2026 Earnings EPS Beats Estimates by 117 Amid Modest Stock Decline RB Global Inc Q1 2026 Earnings EPS Slightly Beats Estimates Shares Edge Higher Powell Industries Q1 2026 Earnings EPS Misses Estimates Amid Revenue Discrepancy PZG Q1 2026 Earnings Significant EPS Miss Reflects PreRevenue Exploration Stage Dianthus Therapeutics Q1 2026 Earnings EPS Beat Driven by Cost Discipline Yet Shares Slip